A Business at a Glance
0 of 1 daily views used (1 remaining). Sign up free for +5 more daily views (6 total), or try AAPL for a full preview.
VERDE BIO HOLDINGS, INC.
APHD
$2.9B
Mkt Cap
$1.70
+0.00%
VERDE BIO HOLDINGS, INC. (APHD) has a 5-year average return on invested capital (ROIC) of -83.3%. This is below average and may indicate limited pricing power.
VERDE BIO HOLDINGS, INC. (APHD) has a market capitalization of $3.3B. It is classified as a mid-cap stock.
VERDE BIO HOLDINGS, INC. (APHD) does not currently pay a regular dividend.
VERDE BIO HOLDINGS, INC. (APHD) operates in the Crude Petroleum & Natural Gas industry, within the Energy sector.
VERDE BIO HOLDINGS, INC. (APHD) generated $-879 thousand in free cash flow in its most recent fiscal year. Negative free cash flow may indicate heavy investment or operational challenges.
VERDE BIO HOLDINGS, INC. (APHD) has a debt-to-equity ratio of 0.13. This indicates a conservatively financed balance sheet.
VERDE BIO HOLDINGS, INC. (APHD) reported earnings per share (EPS) of $-0.00 in its most recent fiscal year.
Corporate History Verde Bio Holdings, Inc. was incorporated in the State of Nevada on February 24, 2010. On May 1, 2010, the Company entered into a share exchange agreement with Appiphany Technologies Corporation (“ATC”) to acquire all of the outstanding common shares of ATC in exchange for 1,500,000 common shares of the Company. As the acquisition involved companies under common control, the acquisition was accounted for in accordance with ASC 805-50, Business Combinations – Related Issues, and the consolidated financial statements reflect the accounts of the Company and ATC since inception. On February 19, 2019, Media Convergence Group, a Nevada corporation (“Media Convergence”) entered into a certain Stock Purchase Agreement (the “Purchase Agreement”) for the sale of 500,000 shares of the Series A Preferred Stock (the “Preferred Shares”) of the Company. The purchase of the Shares (“Share Purchase”) was closed on November 22, 2019.
| Metric | TTM | FY2023 | FY2022 | FY2019 | FY2018 | FY2017 |
|---|---|---|---|---|---|---|
| Revenue | 32K | - | 0 | 0 | - | 50K |
| Net Income | -2.7M | -1.9M | -3.4M | -537K | -1.5M | - |
| EPS | $-0.00 | $-0.00 | $0.00 | $-0.09 | $-0.00 | $-7.49 |
| Free Cash Flow | 0 | -879K | -4.0M | -16K | -225K | -266K |
| ROIC | -479.3% | -53.0% | -73.5% | -123.3% | -1496.4% | - |
| Gross Margin | - | - | - | - | - | -750.4% |
| Debt/Equity | 1.10 | 0.13 | 0.02 | -0.02 | -0.02 | -0.02 |
| Dividends/Share | $0.00 | - | - | - | - | - |
| Operating Income | -1.4M | -1.6M | -3.2M | -37K | -451K | -456K |
| Operating Margin | -4576.8% | - | - | - | - | -906.7% |
| ROE | -2234.8% | -64.2% | -95.9% | 30.4% | 97.3% | - |
| Shares Outstanding | 1,932M | 1,683M | 7M | 6M | 368M | - |
| Metric | ||||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Income Statement | ||||||||||||
| Revenue | N/A | N/A | N/A | 9K | 0 | N/A | 50K | N/A | 0 | 0 | N/A | 32K |
| Gross Margin | N/A | N/A | N/A | N/A | N/A | N/A | -750.4% | N/A | N/A | N/A | N/A | N/A |
| R&D | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| SG&A | 44K | 23K | 13K | -2K | 57K | 17K | 79K | 88K | 14K | 382K | 358K | 618K |
| EBIT | -127K | -151K | -161K | -134K | -234K | -196K | -456K | -451K | -37K | -3.2M | -1.6M | -1.4M |
| Op. Margin | N/A | N/A | N/A | -1538.2% | -90510.1% | N/A | -906.7% | N/A | N/A | N/A | N/A | -4576.8% |
| Net Income | -129K | -145K | -121K | N/A | N/A | -126K | N/A | -1.5M | -537K | -3.4M | -1.9M | -2.7M |
| Net Margin | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -8437.4% |
| Non-Recurring | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Returns on Capital | ||||||||||||
| ROIC | N/M | N/M | N/M | N/A | N/A | N/M | N/A | N/M | -123.3% | -73.5% | -53.0% | N/M |
| ROE | 121.8% | 80.8% | 58.7% | N/A | N/A | 23.6% | N/A | 97.3% | 30.4% | -95.9% | -64.2% | -2234.8% |
| ROA | -888.2% | -1226.3% | -750.1% | N/A | N/A | -17293.6% | N/A | -3682.7% | -2259.0% | -67.7% | -40.3% | -141.3% |
| Cash Flow | ||||||||||||
| Op. Cash Flow | -84K | -33K | -188K | -52K | -62K | -9K | -266K | -225K | -16K | -1.2M | -872K | -1.1M |
| Free Cash Flow | -86K | -35K | -190K | -54K | -62K | -9K | -266K | -225K | -16K | -4.0M | -879K | 0 |
| Owner Earnings | -85K | -34K | -189K | -54K | -62K | -9K | -314K | -225K | -16K | -1.2M | -934K | -1.2M |
| CapEx | 2K | 2K | 2K | 2K | 0 | 0 | 0 | 0 | 0 | 2.9M | 7K | 0 |
| Maint. CapEx | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 26K | 62K | 149K |
| Growth CapEx | 1K | 1K | 1K | 0 | N/A | N/A | N/A | N/A | N/A | 2.8M | 0 | 0 |
| D&A | 0 | 0 | 0 | 2K | 0 | 0 | 0 | 0 | 0 | 26K | 62K | 149K |
| CapEx/OCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% |
| Capital Allocation | ||||||||||||
| Dividends Paid | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Dividend Yield | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Share Buybacks | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 |
| Buyback Yield | N/A | N/A | 0.0% | N/A | N/A | N/A | N/A | N/A | N/A | 0.0% | 0.0% | 0.0% |
| Stock-Based Comp | N/A | N/A | N/A | N/A | N/A | 0 | 49K | 0 | N/A | N/A | N/A | N/A |
| Debt Repayment | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 0 | 5K | 217K | 217K |
| Balance Sheet | ||||||||||||
| Net Debt | 14K | 24K | 32K | 54K | 0 | 5K | 32K | 32K | 32K | -204K | 231K | 119K |
| Cash & Equiv. | 13K | 8K | 0 | 5K | 0 | 0 | 0 | 0 | 0 | 141K | 26K | 12K |
| Long-Term Debt | 27K | 0 | N/A | N/A | N/A | N/A | N/A | 0 | N/A | N/A | N/A | 65K |
| Debt/Equity | -0.16 | -0.17 | -0.15 | -0.22 | 0.00 | -0.01 | -0.02 | -0.02 | -0.02 | 0.02 | 0.13 | 1.10 |
| Interest Coverage | -56.8 | -410.6 | -61.7 | -34.0 | -1.8 | -10.0 | -2.5 | -1.5 | -0.1 | N/A | -24.9 | -24.9 |
| Equity | -165K | -195K | -216K | -269K | -587K | -476K | -1.5M | -1.5M | -2.0M | 3.6M | 2.2M | 119K |
| Total Assets | 15K | 9K | 23K | 5K | 0 | 1K | 57K | 24K | 24K | 5.1M | 4.2M | 1.9M |
| Total Liabilities | 179K | 205K | 239K | 275K | 587K | 477K | 1.6M | 1.5M | 2.0M | 1.5M | 1.8M | 1.6M |
| Intangibles | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Retained Earnings | N/A | N/A | N/A | -868K | -1.7M | -1.8M | -3.9M | -5.4M | -5.9M | -14M | -16M | -18M |
| Working Capital | -31K | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | -1.2M | -1.7M | -119K |
| Current Assets | 13K | 8K | 23K | 5K | N/A | N/A | N/A | N/A | N/A | 296K | 98K | 104K |
| Current Liabilities | 45K | N/A | N/A | N/A | N/A | N/A | N/A | 424K | N/A | 1.5M | 1.8M | 223K |
| Per Share Data | ||||||||||||
| EPS | -0.01 | -0.01 | -0.01 | -3.32 | -4.85 | -0.01 | -7.49 | -0.00 | -0.09 | 0.00 | -0.00 | -0.00 |
| Owner EPS | -0.01 | -0.00 | -0.01 | N/A | N/A | -0.00 | N/A | -0.00 | -0.00 | -0.17 | -0.00 | -0.00 |
| Book Value | -0.02 | -0.02 | -0.01 | N/A | N/A | -0.03 | N/A | -0.00 | -0.34 | 0.53 | 0.00 | 0.00 |
| Cash Flow/Share | -0.01 | -0.00 | -0.01 | N/A | N/A | -0.00 | N/A | -0.00 | -0.00 | -0.17 | -0.00 | -0.00 |
| Dividends/Share | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | 0.00 |
| Shares Out. | 10.7M | 12.0M | 19.9M | N/A | N/A | 14.9M | N/A | 367.5M | 5.9M | 6.7M | 1.7B | 1.9B |
| Valuation | ||||||||||||
| P/E Ratio | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| P/FCF | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| EV/EBIT | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Book | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A | N/A |
| Price/Sales | N/A | N/A | N/A | 487.4 | N/A | N/A | 48.4 | N/A | N/A | N/A | N/A | N/A |
| FCF Yield | -6.7% | -4.0% | N/A | -28.8% | -10.3% | -0.0% | -24.7% | -25.8% | -5.9% | N/A | N/A | N/A |
| Market Cap | 1.3M | 873K | 0 | 186K | 597K | 26M | 1.1M | 874K | 279K | 0 | 0 | 3.3B |
| Avg. Price | 37.56 | 85.39 | 0.00 | 31.83 | 19.43 | 4.12 | 5.66 | 1.39 | 1.56 | 0.00 | 0.00 | 1.70 |
| Year-End Price | 50.00 | 30.00 | 0.00 | 25.00 | 3.75 | 9.98 | 2.50 | 1.25 | 1.30 | 0.00 | 0.00 | 1.70 |
VERDE BIO HOLDINGS, INC. passes 0 of 9 quality checks, indicating weak fundamentals.
VERDE BIO HOLDINGS, INC. (APHD) has a return on equity (ROE) of -64.2%. A negative ROE may indicate losses or negative equity.
VERDE BIO HOLDINGS, INC. (APHD) has a 5-year average gross margin of -750.4%. This lower margin is typical of capital-intensive or commodity businesses.
The Ledger Terminal provides 11 years of financial data for VERDE BIO HOLDINGS, INC. (APHD), sourced directly from SEC EDGAR filings. This includes income statements, balance sheets, cash flow statements, and key financial ratios.
VERDE BIO HOLDINGS, INC. (APHD) has a book value per share of $0.00, based on its most recent annual SEC filing.